217 related articles for article (PubMed ID: 7522379)
41. [Accumulation of two different hydroxyethyl starch preparations in the placenta after hemodilution in patients with fetal intrauterine growth retardation or pregnancy hypertension].
Heilmann L; Lorch E; Hojnacki B; Müntefering H; Förster H
Infusionstherapie; 1991 Oct; 18(5):236-43. PubMed ID: 1722779
[TBL] [Abstract][Full Text] [Related]
42. Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases.
Treib J; Haass A; Pindur G; Grauer MT; Treib W; Wenzel E; Schimrigk K
Arzneimittelforschung; 1996 Nov; 46(11):1064-6. PubMed ID: 8955865
[TBL] [Abstract][Full Text] [Related]
43. [Effect of hemodilution with plasma protein solution and hydroxyethyl starch on plasma fibronectin].
Khosropour R; Graninger W; Lackner F
Anasth Intensivther Notfallmed; 1984 Aug; 19(4):175-8. PubMed ID: 6208807
[TBL] [Abstract][Full Text] [Related]
44. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
Jung F; Waldhausen P; Spitzer S; Mrowietz C; Häuser B; Wenzel E
Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
[TBL] [Abstract][Full Text] [Related]
45. [Hypertonic-hyperoncotic volume replacement (7.5% NaCl/10% hydroxyethyl starch 200.000/0.5) in patients with coronary artery stenoses].
Prien T; Thülig B; Wüsten R; Schoofs J; Weyand M; Lawin P
Zentralbl Chir; 1993; 118(5):257-63; discussion 264-6. PubMed ID: 7686707
[TBL] [Abstract][Full Text] [Related]
46. [Colloidal hypertonic solutions in cardiac surgery].
Boldt J; Hammermann H; Hempelmann G
Zentralbl Chir; 1993; 118(5):250-6. PubMed ID: 7686706
[TBL] [Abstract][Full Text] [Related]
47. [A new hydroxyethyl starch for volume replacement: Elohes 6%].
Medel J; Baron JF
Rev Esp Anestesiol Reanim; 1998 Nov; 45(9):389-96. PubMed ID: 9847657
[TBL] [Abstract][Full Text] [Related]
48. Effect of an equal volume replacement with 500 mL 6% hydroxyethyl starch on the blood and plasma volume of healthy volunteers.
Mortelmans Y; Merckx E; van Nerom C; Verbruggen A; van Aken H; de Roo M; Mortelmans L
Eur J Anaesthesiol; 1995 May; 12(3):259-64. PubMed ID: 7543845
[TBL] [Abstract][Full Text] [Related]
49. [Acetyl starch as volume substitute, a possible alternative to HES].
Asskali F; Warnken U; Förster H
Dtsch Med Wochenschr; 2001 Jan; 126(1-2):1-6. PubMed ID: 11200658
[TBL] [Abstract][Full Text] [Related]
50. Action of hydroxyethyl starch (HES) on the activity of plasmatic clotting factors.
Langer R; Jordan U; Wölfle A; Henrich HA
Clin Hemorheol Microcirc; 1998 Jul; 18(2-3):103-16. PubMed ID: 9699031
[TBL] [Abstract][Full Text] [Related]
51. Effects of a hydroxyethylstarch solution on plasma colloid osmotic pressure in acutely ill patients.
Mbaba Mena J; De Backer D; Vincent JL
Acta Anaesthesiol Belg; 2000; 51(1):39-42. PubMed ID: 10806521
[TBL] [Abstract][Full Text] [Related]
52. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
[TBL] [Abstract][Full Text] [Related]
53. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
[TBL] [Abstract][Full Text] [Related]
54. [Continuous hemodilution using a low-molecular hydroxyethyl starch solution. Pilot studies in patients with acute cerebral ischemia].
Fuchs M; Henkel P; Becker-Scheid D; Schmitt J
Infusionstherapie; 1990 Aug; 17(4):205-9. PubMed ID: 1698719
[TBL] [Abstract][Full Text] [Related]
55. Plasma substitutes.
Boldt J; Suttner S
Minerva Anestesiol; 2005 Dec; 71(12):741-58. PubMed ID: 16288182
[TBL] [Abstract][Full Text] [Related]
56. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis.
Niemi TT; Kuitunen AH
Acta Anaesthesiol Scand; 2005 Mar; 49(3):373-8. PubMed ID: 15752404
[TBL] [Abstract][Full Text] [Related]
57. In cardiac surgery patients does Voluven(R) impair coagulation less than other colloids?
Raja SG; Akhtar S; Shahbaz Y; Masood A
Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):1022-7. PubMed ID: 21398650
[TBL] [Abstract][Full Text] [Related]
58. Effects of hypertonic saline (7.5%) on extracellular fluid volumes compared with normal saline (0.9%) and 6% hydroxyethyl starch after aortocoronary bypass graft surgery.
Järvelä K; Koskinen M; Kaukinen S; Kööbi T
J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):210-5. PubMed ID: 11312481
[TBL] [Abstract][Full Text] [Related]
59. [Comparison of volume substitutes 5 percent human albumin and 6 percent hydroxyethyl starch (40,000/0.5) in pediatric anesthesia].
Hausdörfer J; Hagemann H; Heine J
Anasth Intensivther Notfallmed; 1986 Jun; 21(3):137-42. PubMed ID: 2428266
[TBL] [Abstract][Full Text] [Related]
60. [The effect of 6% HES 200/0.6-0.66 on plasma volume and blood coagulation].
Kröll W; Gerner P; Colombo T; Ramschak H; Hinghofer-Szalkay H; List WF
Infusionsther Transfusionsmed; 1992 Aug; 19(4):171-80. PubMed ID: 1384845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
